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ABSTRACT
Nowadays, a large number of compounds derived from plants are used in modern
medicine and a majority of them are inspired by traditional applications. About 60% of
anticancer drugs and 75% of compounds for infectious diseases are either natural products
or their derivatives. However, it is estimated that only bioactive molecules of 5 to 15% of
more than 250'000 plants species on earth have been investigated. Particularly, few
scientific studies have been conducted on bioactive compounds from the medicinal plants
of the boreal forest, wide-spread in Quebec and Canada. In recent years, LASEVE
laboratory has evaluated the potential pharmacology of many plants and it was apparent
that the buds of Populus tremuloides would represent an interesting subject of study in
chemistry and pharmacology. In North America, leaf-buds of P. tremuloides were used in
traditional medicine to treat numerous diseases. The aim of this research project was to
isolate and characterize the polyphenolic constituents in buds of P. tremuloides and to
evaluate the biological activities of the purified fractions and pure compounds.
Phytochemical investigations of the EtOH extract of P. tremuloides leaf-buds led to the
isolation of 24 phenolic compounds. Among them, one compound is a new molecule and
was not reported in literature before; two compounds were not reported before for
Salicaceae family; two compounds were not reported before for Populus genus; and ten
compounds were identified for the first time in P. tremuloides. Three of the identified
compounds have exhibited a moderate to strong cytotoxicity (5-20 uM) towards some of
cellular tested lines (WS1, DLD-1, A-549). Anti-inflammatory activity of five phenolic
compounds having a glycerol section has been evaluated using LPS-stimulated RAW 264.7
macrophages. Only one of the tested compounds significantly inhibited nitric oxide
production (IC50: 6.5 ± 0.4 uM), without cytotoxicity. Finally, none of the phenolic
compounds isolated in the present work have exhibited a significant activity against
Staphylococcus aureus and Escherichia coli.
mRESUME
De nos jours, un grand nombre de composés d'origine végétale sont utilisés dans la
médecine moderne. Plusieurs d'entre eux ont été développés en s'inspirant des
informations de la médecine traditionnelle. Environ 60 % des anticancéreux et 75 % des
antimicrobiens de l'arsenal thérapeutique actuel sont des produits naturels ou des dérivés.
Seulement 5-15 % des 250 000 plantes ont été étudiées afin d'en évaluer le potentiel
pharmacologique. Les plantes de la forêt boréale québécoise ont été très peu étudiées au
niveau de leur composition chimique et de leur potentiel pharmacologique. Au cours des
dernières années, le laboratoire LASEVE a évalué le potentiel pharmacologique de
plusieurs plantes et il en est ressorti que les bourgeons du Populus tremuloides
représentaient un sujet d'étude intéressant au niveau chimique et pharmacologique. De
plus, cette espèce a été utilisée en médecine traditionnelle pour traiter de nombreuses
maladies. L'objectif de ce projet était d'isoler et de caractériser les composés phénoliques
majoritaires des bourgeons de Populus tremuloides et d'en évaluer l'activité biologique
(anticancéreuse, anti-inflammatoire et antibactérienne). Les travaux effectués sur l'extrait
éthanolique des bourgeons de Populus tremuloides ont mené à l'identification de 24
composés phénoliques. Un de ces composés n'a jamais été rapporté auparavant dans la
littérature scientifique et deux autres n'ont jamais été signalés dans la famille des
Salicacées. De plus, dix de ces composés sont identifiés pour la première fois dans le
Populus tremuloides. Trois des composés identifiés ont démontré une cytotoxicité de forte
à modérée (5-20 uM) envers certaines des lignées cellulaires testées (WS1, DLD-1, A-549).
L'activité anti-inflammatoire de cinq composés phénoliques constitués d'une section
glycérol a été évaluée sur des macrophages de souris RAW 264.7 stimulé avec le LPS
(lipopolysaccharide). Un seul des composés testés a significativement inhibé, sans
cytotoxicité, la production d'oxyde nitrique avec une IC50 de 6.5 ± 0.4 uM. Finalement,
aucun des composés phénoliques isolés dans ces travaux n'a démontré une activité
importante contre Staphylococcus aureus et Escherichia coli.
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Chapter I
INTRODUCTION
1.1 General Introduction
The use of plants as medicines has a long history. Written proofs of man's ingenuity in
using plants for treatment of various diseases are present by ancient Chinese, Indians, and
North Africans [1]. These plants were initially used without modification, then as
concentrated extracts to increase their effectiveness or as dried form to keep them for
longer times with less degradation. In the 1900s, people learned how to isolate active
compounds from medicinal plants.
Even today, natural products are important sources of drugs and almost 60% to 75% of
the world's population use plant-based medicines for initial pharmaceutical cure [2].
Between 1981 and 2002, it is estimated that almost 50 % of new chemical entities
authorized to initiate clinical studies were natural products or related natural products [3].
Moreover, natural products exhibiting various biological activities usually possess a
complex and diverse structure leading to strong challenges in organic synthesis [3, 4],
About 60% of anticancer drugs and 75% of compounds for infectious diseases are either
natural products or their derivatives [5, 6]. It is commonly accepted that less than 15 % of
the plants were studied regarding their biological activities [7, 8].
In Canada, one of the most important natural resources is the boreal forest. The latter
plays an important role in the traditional medicine of Canadian First Nations communities
[9]. However, real effectiveness of these potential drugs is rarely studied in scientific ways.
Few biophamiaceutical studies were undertaken on plant species of the boreal forest of
Canada [9, 10]. Based on the knowledge acquired by First Nations communities, LASEVE
laboratory reported the identification of an antitumoral compounds from balsam fir [11].
Following this result, a large effort of this laboratory has been devoted to research on
potential pharmaceutical contents in biomass of the boreal forest.
This project is inspired by previous research work performed on other Populus species
{Populus balsamiferd). The present research is focused on chemical and biological
properties of bud constituents of the most widely distributed species of Populus in boreal
forest, named Populus tremuloides.
1.2 Research objectives
The main goals of this research project are:
• Isolation and characterization of polyphenolic constituents from the buds of P.
tremuloides.
• . Investigation of crude extract, purified fractions and pure compounds for
antibacterial, anti-inflammatory and cytotoxic activities (in vitro).
• Identification of the active compound(s) through bioassay-guided fractionation.
• Study of the relationship between the chemical structures and the biological
activities.
This thesis is divided into five chapters. The first chapter is dedicated to the thesis
outlines. Chapter II covers literature reviews about botany, applications and phytochemistry
of the genus Populus and the species of Populus tremuloides. Chapter III presents a
4scientific paper dealing with Cytotoxic polyphenols in leaf-buds of P. tremuloides. This
article was accepted in Canadian Journal of Chemistry. Chapter IV describes the scientific
work related to anti-inflammatory phenolic compounds from buds of Populus tremuloides
and finally in Chapter V, conclusions and future directions are covered.
Chapter II
LITERATURE REVIEW; Populus tremuloides Michx
2.1 Principle Characteristics ofPopulus tremu!oides
Populus tremuloides (Quaking aspen), from Salicaceae family is a decidous tree native
to cooler areas of North America. It is a tall tree, usually 20 to 25 meters high at maturity,
with a trunk diameter comprised between 20 to 80 cm [12, 13]. As shown in figure 1, this
tree has a geographical distribution from Alaska to the east coast of Canada and is present
down south in scattered populations (New Mexico state). However, It is absent from the
central and south-eastern plains. It grows in humid calcium-rich soils.
(a) (bf (c)
Figure 1: (a) Distribution of P. tremuloides in North America, (b) trees of'P. tremuloides,
(c) leaves of P. tremuloides [13, 19].
2.2 Applications by Amerindians
Quaking aspen has been used as herbal medicine for centuries. First Nations
communities widely used this species especially for its antiseptic and analgesic properties
for wounds healing and against skin complaints and disorders [9]. Now, it has similar
applications in modern herbalism.
7Its bark had applications in the treatment of rheumatism, arthritis, gout, lower back
pains, urinary complaints, digestive and liver disorders, debility, and anorexia [14-16]. It
also could reduce fevers and relieve the pain of menstrual cramps [16]. Infusion of inner
bark was a remedy for coughs as well as a treatment for stomach pains, colds and fever [16-
17].
Leaf-buds had applications as a nasal salve for children and adults to fight coughs, colds
and irritated nostrils [9, 18]. They were also used against chronic bronchitis and
rheumatism and externally for treating superficial wounds, external haemorrhoids, frostbite,
sunburn and as an ointment for myalgia [19].
2.3 Chemistry of tne genus Populus
Having fast growth rates, the genus Populus attracted many economical interests, such
as in the wood pulp industry and motivated longstanding investigations about its chemistry
[20]. The genus tree family contains phenolic glycosides which are important secondary
metabolites regarding plant resistance to both insect and mammalian herbivores [21, 22].
Finally, chemical principles from Populus species are known to have various biological
activities such as fungicidal, antioxidant, antitumor, antiseptic and antiviral properties [23-
25].
Several classes of natural products such as polyphenols, terpenoids, fatty acids, aliphatic
alcohols and hydrocarbons are found in the genus Populus [26-29]. Due to difficulty in
identification of Saiicaceae species only based on morphological identification, secondary
phenolics were used as chemotaxonomic purposes. The chemotaxonomy of poplar
(Populus spp) is related to a complex mixture of compounds in their bud exudates which
include benzoic and phenolic acids and their esters, fiavanoid aglycones, hydrocarbons and
terpenoids [30, 31]. The presence of some phenolic compounds can be used as a
'fingerprint' to identify poplar species [32] since many phenolic components of buds
exudates of European, Asian, and North American poplar species have been studied in
recent years [33-38]. The analysis of poplar bud exudates have shown a high degree of
complexity. The typical poplars of a particular section have a bud exudate composition
which is characteristic of that section. For example, section Leuce, subsection Albidae, e.g
P. alba L., exude only hydrocarbons [39] whereas those of subsection Trepidae, e.g. P.
tremuloides Michx., secrete a phenolic exudate which includes only the flavanones
produced by the first steps of flavonoid metabolism, such as naringenin (S,7,4'-
trihydroxyflavonone) and its methyl ethers [29]. By contrast poplars of section Aigeiros,
such as P.deltoides Marsh [40] and P.nigra L. [41], and of section Tacamahacha, such as
P.balsamifera L. [42], produce a more complex bud exudate, which contains primarily
flavonoids resulting from the further metabolism of naringenin. Phenolic compounds are
also exuded onto the leaf surfaces of some poplars, such as P. deltoïdes [43] and P. nigra
[44]. The bud of P. tremuloides is shown in figure 2.
Propolis, a resinous hive product collected by honeybees from parts of plants, especially
buds and exudates of Populus species, has been used as folk medicines about 300 years
before Christ (BC). Different biological activities, such as anticancer, antioxidant, anti-
inflammatory, antibiotic and antifungal effects have been reported for propolis and its
constituents. It has also been extensively used in food and beverages to improve health and
prevent diseases such as inflammation, heart disease, diabetes and even cancer. Recently
there is a renewed interest in the composition of propolis and related poplars [45-48].
Recently, it has been proven that the phenolic content of northern propolis is mainly
inherited from Populus spp., a very attractive tree for honey bees of Canada. Thus,
considering the promising biologically-active substances in propolis inheritated from
poplars of section Leuce, subsection Trepidae, its plant source which is P. tremuloides is
worth further investigation [49].
Figure 2: Bud of Populus tremuloides.
2.4 Populus tremuloides Michx
While P. tremuloides has a rather prominent importance as a model system for
ecological and environmental research by the forest industries, few phytochemical or
pharmacological studies were conducted so far on P. tremuloides. Fernandez et al. has
identify 44 compounds (12 of them are shown in figure 3) such as phenolic compounds,
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fatty acids, steroids, triterpenes and lipids in processing of P. tremuloides Michx. for pulp
and paper, with a rapid gas chromatography-mass spectrometry (GC-MS) method,
summarized in table 1 [50].
Stignnast-5-en-3p-ol O!eanen-3(3-ol Tirucalle-7-,24-diene-3p-ol
Cyc!oart-24-en-3p-ol 12-Ursen-3|3-ol 24-Methylcydoart-24,(24')-en-3p-o!
RO
Citrostadienol 20(29)-Lupen-3p-yl R a-Tocopherol
0
OH O OH
5,4'-Dihydroxy-7methoxyfiavanone 3-(4-Hydroxypheny!)-2-propenoicacid Hexadecanoic acid
Figure 3: Molecular structure of some compounds described by Fernandez et al [50].
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Table 1: GC-MS identification of the P. tremuloides pulp and paper constituents [1].
Compound family
Monoaryl phenolics
Fatty acids
Flavonoids
Sterols / triterpene alcohols
Steryl / triterpene esters
Lipids
Name of compounds
benzoic acid
1 -Etliyi-4-hydroxybenzene
3-(2-Hydroxyphenyl)-2-propenoic acid
2-hydroxybenzyl alcohol
4-Hydroxy-2-methyiacetophenone
4-Hydroxybenzoic acid
3-(4-Hydroxyphenyl) propanoic acid
3-(4-Hydroxy-3-methoxyphenyl)-2-propen-l-ol
3-(4-Hydroxy-3-methoxyphenyi)-2-propenal
3~(4-Hydroxyphenyl)-2-propenoic acid
4-(4-Hydroxy-3-methoxyphenyl)-2-propenoicacid
4-(3-Hydroxy-l-propenyl)-2,6-dimethoxyphenol
3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propen-lal
9-oxononanoic acid
Hexadecanoic acid
(Z,Z)-9,12-Octadecadienoic acid
Octadecadienoic acid
Eicosanoic acid
Docosanoic acid
Tetracosanoic acid
] -Docosanol
4 ' ,5 -Dihydroxy-7-methoxyflavanone
4',5,7-Trihydroxyflavanone
3,5,7 -Trihydroxy-4 ' -methoxy flavone
3,4',5,7-Tetrahydroxyflavone
Stigmast-5-en-3P-oi
Oleanen-3P-ol
Tirucalla-7,24-diene-3p-ol
Cycloart-24-en-3p-ol
12-Ursen-3|3-ol
24-Methylcycloart-24,(24)-en-3|3-ol
Citrostadeniol
Stigmast-5-en-3P-yl acetate
Tirucalla-7,24-diene-3p-yl hexadecanoate
12-Oleanen-3j}-y] hexadecanoate
20(29)-Lupen-3 P-yl hexadecanoate
12-Ursen-3p-y! hexadecanoate
Tirucalla-7,24-diene-3p-yl octadecanoate
12-Oleanen-3p-y! octadecanoate
20(29)-Lupen-3P-yl octadecanoate
12-Ursen-3P-yl octadecanoate
Tiraculla-7,24-diene-3p-yl eicosanoate
a-tocophérol
(9Z. 12Z)-Glycerol tri-9, ! 2-octadecadienoate
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The extractives of unsaturated alcohol fraction from P. tremuloides heartwood have
been studied by Abramovitich and Micetich [51] and their work resulted in the
identification of triterpenes and sterols, as shown in figure 4.
AcO AcO'
a-amyrin acetate p-amyrin acetate a-amyrenonol
AcO'
lupeol acetate
AcO'
24-methylenecycloartanol butyrospermol acetate
Figure 4: Triterpenes constituents from the heartwood of P. tremuloides [51].
Pearl et al. [52] showed that leaves of P. tremuloides provide a good source of the 6-
monobenzoate of salicin, populin, while the bark of the same species provides a good
source of the 2-monobenzoate of salicin, tremuloidin [52, 53]. Lindroth et al. [54]
identified phenolic glycosides components, such as salicin, salicortin, tremuloidin,
tremulacin from the crude extract of P. tremuloides leaves which exhibited differential
toxicity against the insects such as Papilio glaucus subspecies.
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Phytochemical investigation by English et al. [29] with GC-MS on buds of P.
tremuloides revealed phenolic compounds, flavonoids and hydrocarbons listed in table 2.
Table 2: Components of buds of P. tremuloides [29].
Compound family
Phenolic compounds
Flavonoides
Hydrocarbones
(straight chain)
Hydrocarbon alcohol
Name of compounds
Benzyl benzoate
p-Coumaric acid
Ferulyl alcohol
Ferulic acid
Caffeic acid
Benzyl j?-coumarate
Ferulyl benzoate
Benzyl ferulate
Benzyl caffeate
Isosakuranetin
Isosakuranetin chalcone
Sakuranetin
Sakuranetin chalcone
Kaempferol methyl ether
Tricosane
Pentacosane
Heptacosane
Nonacosane
1 -Hexacosanol
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Populus tremuioides.
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Graphical abstract
Bioassay-guided fractionation and separation of the EtOH extract of Populus
tremuloides leaf-buds resulted in the isolation of a new compound. (lS,2S)-l-[4-O-(E)-
coumaroyl-/?-D-glucopyranosyloxy]cyclohexane-diol 1, and 18 known products. In vitro
cyto toxic and antibiotic activities were evaluated for 18 of them.
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Résumé
Les enquêtes phytochirnique menés sur l'extrait éthanolique des feuilles-bourgeons du
P. tremuloides ont conduit à l'isolement de 19 composés phénolique. Parmi eux, on y
trouve est une nouvelle molécule, (IS, 2S) -1 - [4-O-E-coumaroyl p-D-glucopyranosyloxy]
cyclohexanediol. La structure de cette dernière a été déterminée par spectroscopie (RMN et
MS) et par des méthodes chimiques. Les autres Dix-huit composés isolés ont été testés pour
l'activité cytotoxique en comparaison avec celle des lignées cancéreuses des poumons
(A549) et celle du côlon (DLD-1) présent dans les cellules humaines affectés. L'activité
antibactérienne a également été évaluée contre VEscherichia coli et le Staphylococcus
aureus.
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Abstract
Phytochemical investigations of the EtOH extract of Populus tremuloides leaf-buds led
to the isolation of 19 phenolic compounds. Among them, (IS, 25)-l-[4-O-i?-coumaroyl-/5-
D-glucopyranosyloxy]cyclohexanediol was reported for the first time and its structure was
determined by spectroscopic (NMR and MS) and chemical methods. Seventeen of isolated
compounds were tested for their cytotoxicity against lung carcinoma (A549) and colorectal
adenocarcinoma (DLD-1) human cell lines. Antibacterial activity was also evaluated
against Escherichia coli and Staphylococcus aureus.
Keywords
Quaking aspen; coumarate; flavonoids; NMR.
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Introduction
The buds exudates of many plant species of Populus genus are known as raw material
processed by bees into propolis (1). The latter product has been widely used in popular
medicine as antibacterial (2-4), anti-inflammatory (5), antioxidant (6-7) and cytostatic
treatments (8). The biological activity of propolis samples is mainly due to phenolic
compounds like flavonoids, aromatic acids and diterpenic acids (9-10) which are the
principal constituents of the buds of Populus species (11-13). Recently, studies in the
northern-type propolis showed a potential source of biologically-active substances in P.
tremuloides (14) which are widely spread across North America (15). In spite of its use as
ointment by Amerindian traditional medicine to treat numerous diseases such as coughs,
colds and irritated nostrils (16), few studies were carried out on the medicinal applications.
In the present study, the isolation and structure elucidation of a new phenolic compound
from Populus tremuloides Michaux, along with 18 known products are described.
Experimental
General
Optical rotations were measured with an automatic polarimeter Rudolph Research
Analytical Autopol IV. FTIR spectra were recorded with a Perkin-Elmer SpectrumOne.
High resolution electrospray ionization mass spectrum was conducted in positive mode
with an Applied Biosystems/MDS Sciex QSTARXL QqTOF MS system. The ID and 2D
NMR spectra ( ' H - !H COSY, HSQC and HMBC) were performed using an Avance 400
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Bruker spectrometer equipped with a 5 mm QNP-probe. Chemical shifts were expressed in
8 (ppm) units relative to TMS as an internal standard and coupling constants were given in
Hertz. Preparative HPLC was performed on an Agilent 1100 liquid chromatography
system, equipped with a solvent delivery system, an autosampler and a UV-MWD detector.
Samples were eluted in an Intertsil prep-ODS column C18 (20 x 250 mm; 10 um) at room
temperature with a flow rate of 10 mL min'1. The GC-MS analysis were performed with an
instrument (Agilent Technologies 6890N) fitted with a mass selective detector (Agilent
Technologies 5973), a split-splitless injection port and an apolar capillary column DB-5MS
(30 m x 0.25 mm x 0.25 um).
Analytical thin-layer chromatography was performed with silica gel 60 F254, 0.25 mm
pre-coated TLC plates (Silicycle, Québec, Canada). Flash column chromatographies were
performed on silica gel (40-63 um with indicator F254, Silicycle, Québec, Canada) and on
Ci8 reversed phase silica gel (carbon 11 %, 40-69 urn, Silicycle, Québec, Canada).
Polyamide CC-6 was purchased from Macherey-Nagel (Germany) and Diaion HP-20 from
Supelco. Detection of the phenolic compounds was carried out by spraying TLC plates with
polyethylene glycol (NP/PEG) reagent followed by heating at 110 °C and detected by UV
absorption at 254 and 365 nm. TLC identification of monosaccharides were performed with
CHaClr-MeOH—I^O (50:25:5) solvent system. The compounds were visualized by
spraying an orthophosphoric acid solution of naphtoresorcinol 5 % in EtOH, followed by
heating at 110 °C.
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The commercial samples used for biological tests, namely prunin (3), kaempferide (13)
and trans-ferulic acid (19), were purchased from Indofine Chemical Company (USA).
Rhamnocitrin (10) was purchased from Apin Chemicals Ltd (UK).
Plant materia!
Leaf-buds of Populus tremuloides Michaux were collected in the boreal forest to the
south of Chicoutimi, Québec, Canada, in April 2006. Samples were identified by Patrick
Nadeau (Département des sciences fondamentales, Université du Québec à Chicoutimi). A
voucher specimen (QFA-A540466) was deposited at the Herbarium Louis-Marie of
Université Laval, Québec, Canada.
Extraction and Isolation
The buds of Populus tremuloides (1 kg) were exhaustively extracted with EtOH (3 L, 60
°C, 3 times, 2 h each time) followed by EtOH-H2O (7:2). The extracts were filtered and
pooled. After evaporation of EtOH in vacuo, the aqueous phase was extracted successively
with hexane (500 mL x 5) and saturated M-BUOH with H2O (500 mL x 5). The n-BuOH
phase was decanted and evaporated in vacuo. The residue (80 g) was fractionated using an
open Diaion® column eluted with H2O-MeOH with 30 %, 50 % and 80 % of MeOH.
Three fractions were obtained: A (6.46 g), B (7.24 g) and C (58.96 g).
Fraction C was purified on silica gel CC, eluted with CHCl3-MeOH gradient (60:1—>5:1,
v/v) and three fractions were obtained. Fr. Cl (16.73 g) was subjected to silica gel using a
gradient of CHCl3-MeOH (90:1-^60:1, v/v) as eluent. Subfr. Cl.l (384 mg), obtained from
CHCl3-MeOH (90:1), was separated on silica gel CC with CHCl3-MeOH (80:1) as eluent,
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to give three fractions. Subfr. C1.1A was purified by preparative HPLC with a gradient
elution of MeOH-H2O (50:50—»85:15, v/v) yielding compounds 15 (249 mg), 16 (5 mg)
and 17 (41 mg). Subfr. C1.1B (2.36 g) was applied successively on a silica gel CC and a
reversed-phase CC using gradients MeOH-EbO (50:50—>-70:30, v/v) as eluent to give 11
(160 mg). Compound 9 (3 mg), 12 (18 mg) and a mixture of 10 and 13 (27 mg) were
isolated after a silica gel CC eluted with CHCl3-MeOH (90:1) and a preparative HPLC
(isocratic CH3CN-H2O 40:60) of Fr. C1.2. Compound 18 (50 mg) was obtained from
fraction C1.3 (294 mg) after repeated silica gel CC (CHCI3-MeOH 75:1) and Polyamid
flash column (MeOH-B^O, 50:50-^75:25). Fr. C2 was chromatographed on silica gel CC
with a gradient elution of CHCl3-MeOH (75:1 —>15:1, v/v) to give eight fractions. Subfr.
C2.7 (558 mg) was separated by preparative HPLC using an isocratic mobile phase of
CH3CN-H2O-HCOOH (40:60:1) to afford 2 (19 mg) and 14 (3 mg).
Fr. C3 (5.4 g) was purified on silica gel using a gradient of CHCl3-MeOH (25:1—>7:1) for
elution to give five subfractions. C3.2 was separated on silica gel CC with CHCl3-MeOH
(20:1) giving 6 (289 mg). Some purifications on different silica gel CC of subfr. C3.2.1
permitted to obtain 19 (2 mg). Subfr. C3.4 (418 mg) was separated by preparative HPLC
using an isocratic mobile phase of CH3CN-H2O (30:70) to afford compounds 1 (20 mg), 3
(8 mg), 4 (14 mg) and 8 (37 mg). Subfr. C3.5 (482 mg) was separated by HPLC using a
gradient of MeOH-H2O (10:90 -* 100:0) to give 5 (21 mg) and 7 (35 mg).
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(1 S, 2S)-1 -[4-O-E-coumaroy!-|3-D-g!ucopyranosyloxy3cycIohexanedio!
(1)
White amorphous powder; [a]D25 -35.3° (c 1.0, MeOH); IR (neat) vmax 3328, 2935, 1696,
1602, 1160, 1080, 1024, 982 and 833 cm"1; *H and 13C NMR spectroscopic data, see Table
2; HR-ESI-MS m/z 447.16225 [M+Na]+ (calcd for C2iH28O9Na, 447.16310).
Acid hydrolysis of (1)
Compound 1 was dissolved in HC1 10 % and heated at 110 °C for 4 h. The resulting
hydrolysate was extracted with CHCI3. The organic phase was dried (MgSCH) and the
solvent evaporated under reduced pressure. The presence of />-coumaric acid was confirmed
with standard sample on TLC (CHCl3-MeOH 10:1 as eluent and developing with NP/PEG
reagent). The presence of cyclohexane-1,2-dioI in the organic phase (aD = + 3.4) was
confirmed with a GC-MS analysis: Injector temperature 250 °C; ionization voltage, 70 eV
(EI-MS); column temperature, 40°C for the initial 2 min followed by an increase of 15 °C
min"1 up to 350 °C; carrier gas, He; column flow rate, 1 ml.min'1. Cyclohexane-1,2-diol
was detected at Rt 7.55 min. The aqueous phase was neutralized with N,N-
dioctylmethylamine (10 % in CHCI3) and the solvents were evaporated under reduced
pressure. The residue contained the monosaccharide D-glucose (aD= + 24.8).
Cell lines and culture conditions
Lung carcinoma (A549), colorectal adenocarcinoma (DLD-1) and normal skin fibroblast
(WS1) human cell lines were obtained from the American Type Culture Collection
(ATCC). All cell lines were cultured in minimum essential medium containing Earle's salts
and L-glutamine (Mediatech Cellgro, VA), to which were added 10 % fetal bovine serum
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(Hyclone), vitamins (IX), penicillin (100 I.U. mL"1) and streptomycin (100 \xg mL*1),
essential amino acids (IX) and sodium pyruvate (IX) (Mediatech Cellgro, VA). Cells were
kept at 37 °C in a humidified environment containing 5 % CO2. Antibacterial activity was
tested on Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923E.
Cytotoxicity assay
Exponentially growing cells were plated in 96-well microplates (BD Falcon) at a density
of 5 x 103 cells per well in 100 fiL of culture medium (DMEM with 10 % S VF) and were
allowed to adhere for 24 h before treatment. Increasing concentrations of each compound in
MeOH or DMSO were then added (100 uL per well) and the cells were incubated for 48 h.
The final concentration of MeOH or DMSO in the culture medium was maintained at 0.25
% (v/v) to avoid solvent toxicity. Cytotoxicity was assessed using resazurin (17) on an
automated 96-well Fluoroskan Ascent Fl™ plate reader (Labsystems) using excitation and
emission wavelengths of 530 and 590 nm, respectively. Fluorescence was proportional to
the cellular metabolic activity in each well. Survival percentage was defined as the
fluorescence in experimental wells compared to that in control wells after subtraction of
blank values. Each experiment was carried out thrice in triplicate. IC50 results were
expressed as means ± standard deviation.
Antibacterial assays
Antibacterial activity was evaluated using the microdilution method (42) but with some
modifications: exponentially growing bacteria were plated in 96-well flat bottom
microplates (BD Flacon) at a density of 5 * 103 gram-negative E. coli (ATCC 25922) or
25
40 x 103 gram-positive S. aureus (ATCC 25923) per well in 100 uL nutrient broth (Difco).
The concentration of ethanol in the culture medium was maintained at 0.25 % (v/v) to
avoid solvent toxicity. Fifty microliters of 4 % resazurin was added to each well and the
microplates were incubated for 6 h at 37 °C. Fluorescence was measured after 6 h on an
automated 96-well Fluoroskan Ascent Fl™ plate reader (Labsystems) using excitation and
emission wavelengths of 530 nm and 590 nm respectively.
Results and discussion
The leaf buds of Populus tremuloides were extracted with EtOH and EtOH-EbO under
reflux. After evaporation of EtOH in vacuo, the aqueous phase was successively partitioned
with hexane and «-BuQH. The M-BUOH soluble extract was purified on an open Diaion®
column with a gradient of decreasing polarity and three fractions were obtained. Each
fraction was investigated for in vitro cytotoxic and antibacterial biological activities.
Cytotoxic activity evaluations were carried out on human lung cancer (A549), human
colorectal cancer (DLD-1) and normal skin fibroblasts (WSl) using the resazurin reduction
test as previously described in the literature (17). Antibacterial activity was evaluated
against Escherichia coli and Staphylococcus aureus. The results (Table 1), show that the
last fraction C was found to exert a weak cytotoxic activity against A549 (IC50, 96 ± 7 ug
mL"1) and DLD-1 (IC50, 89 ± 6 ug rnL'1), but was inactive toward bacterial cell lines. Thus,
bioassay-guided fractionation of fraction C was undertaken with a combination of different
chromatographic techniques leading to the isolation of a new compound 1 together with 18
known compounds (figure 1): chaenomeloidin (2) (18), prunin (3) (19), echinaticin (4) (20),
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echinacin (5) (21), tremulacin (6) (22), salicine (7) (23), tremuloidin (8) (24), genkwanin
(9) (25), rhamnocitrin (10) (26), sakuranetin (11) (27), acacetin (12) (28), kaempferide (13)
(29), aromadendrin (14) (30), phenylmethyl coumarate (15) (31), phenethyl p-coumàrate
(16) (32), cinnamyl coumarate (17) (33), phenylmethyl caffeate (18) (34) and trans-ferulic
acid (19) (35). Known compounds were identified by comparison of their spectroscopic
data with the values found in the literature. NMR spectroscopic data for phenethyl p-
coumarate (16), which was also isolated from buds of P. tremuloides, were not available.
Therefore, complete *H and 13C NMR spectroscopic data for 16 are also displayed.
Table 1: In vitro cytotoxicity and antibiotic results of the Diaion® column's fractions21
Samples
Fraction A
Fraction B
Fraction C
Etoposided
Chloramphenicold
IC5o(ngmL-')b
A549
> 100
> 100
96 ±7
2.8 ±0.5
NT'
DLD-1
> 100
> 100
89 ±6
2 ± 1
NT'
WS1
> 100
> 100
80 ± 10
>50
NT'
MICC
S. aurens
> 100
> 100
>100
NT'
>5
E. coli
>100
> 100
> 100
NTe
0.37 ±0.06
a
 Mean values (± standard deviation) for triplicate assays.
b
 Concentration of extract that caused 50 % inhibition of cell proliferation.
c
 Minimum concentration of extract that resulted in inhibition of visible growth
Positive control.
' Not tested.
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14 R1 = H;R2 = OH
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OH O
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RV3
HO 4
9 OR2
15R1 =H;R 2 = CH2-Ph
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6 R1 = H; R2 = CO-Ph; R
7
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HO
Figure 1 : Polyphenoîs from Populus tremuloides
The molecular formula (C21H28O9) of 1, a white amorphous powder, was determined
from its HR-ESI-MS spectrum (positive ion mode) on the basis of a quasimolecular ion
peak at mlz 447.1623 [M+Na]+ (calcd 447.1631). Infrared absorption bands at 3328, 1602,
1160, 982 and 833 cm"1 suggested the presence of hydroxyl groups, aromatic system and an
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ester carbonyl groups. The 13C NMR spectrum (Table 2) displayed 19 carbon signals
separated by DEPT spectrum into five méthylènes, seven aliphatic oxymethines, four
unsaturated methines and three quaternary carbons (one for an ester carbonyl). Among
them, six resonances could be assigned to a sugar moiety. The 'H NMR spectrum
confirmed the presence of a hexose moiety with anomeric proton at SH4.45 (1H, d, J - 7.8
Hz). The *H NMR spectrum also shows the presence of two /rans-olefmic protons at 8H
7.66 (1H, d, J= 15.9 Hz) and SH 6.37 (1H, d, J= 15.9 Hz) and a 1,4-disubstituted aromatic
rings with two protons at SH 7.47 (2H, d, J= 8.6 Hz) and 6.81 (2H, d, J = 8.6 Hz). HMBC
correlations at SH 7.47 (H-2", H-6") and 5C 147.3 (H-7"), 5H 6.81 (H-3", H-5") and 8C 161.5
(C-4") and §H 7.66 (H-7") and 8C 168.6 (C-9") suggested the presence of a coumaroyl
moiety. Analysis of the COSY, HSQC and HMBC spectra led to the identification of a
third aglycone sytem: the cyclohexane-l,2-diol. HMBC correlation between the methine
proton at 8H 4.87 (H-41) and the carbonyl group at 8c 168.6 (C-9") suggested the linkage
between the glucose and the coumaroyl moiety. Finally, the correlation between SH 4.45
(H-l') and Sc 79.4 (C-l), indicated the linkage site of the glucose moiety to the aglycone.
Acidic hydrolysis of 1 and TLC analysis of the aqueous phase afforded identification of
glucose as the sugar component. Absolute configuration of the glucose as D was determined
by optical rotations in comparison with authentic standard. The presence of p-coumaric
acid in the organic phase was confirmed by TLC in comparison with authentic standard.
Cyclohexane-l,2-diol was also detected in the organic phase using GC-MS and NMR
analysis (36). The absolute configuration of cyclohexane-l,2-diol could be determined
directly from the organic phase since the other aglycon part, namely p-coumaric acid, is
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optically inactive. The organic phase showed positive value in optical activity measurement
meaning that (15,25)-cyclohexane-l,2-diol has been isolated (37). The structure of 1 was
thus confirmed as (15, 2,S)-l-[4-O-is-coumaroyl-/?-D-glucopyranosyloxy]cyclohexanediol.
Table 2: 'H (400 MHz) and 13C NMR (100 MHz) spectroscopic data for
compound 1 in methanol-d4.
Position
1
2
3
4
5
6
1'
2'
3'
4'
5'
6'
1"
2", 6"
3", 5"
4"
7"
8"
9"
Sc (mult.)a
79.4 (d)
71.0 (d)
31.5(0
22.4 (0
23.1 (t)
27.6 (0
102.2 (d)
75.1 (d)
75.6 (d)
72.5 \d)
76.1 (d)
62.4 (0
127.2 (s)
131.3 (d)
U6.9(d)
161.5(5)
147.3 (d)
114.8 (J)
168.6(5)
5H (mult.,/in Hz)
3.87 (m)
3.85 (m)
1.79 (m)
1.55 (m)
1.65 (m)
1.34 (m)
1.71 (m)
1.31 (m)
1.82 (m)
1.63 (m)
4.45, (d, 7.8)
3.35 (<W, P.3, 7.8)
3.65 (t 9.3)
4.87 (m)
3.53 (m)
3.62 (cfJ, 15.0, 5.4)
3.54 (m)
7.47 (d, 8.6)
6.81 (rf, 8.6)
7.66(415.9)
6.37 (d, 15.9)
1
 Multiplicities were deduced from DEPT experiments
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Compound 16 has been identified by many authors but surprisingly, no complete NMR
assignation was given (38). Therefore, complete *H and BC characterisation was
accomplished using !H, 13C and 2D spectra (Table 3). First, the same/j-coumaroyl moieties
as in 1 was identified with SH at 6.29 (1H, d, J= 15.9 Hz, H-8), 6.85 (2H, d, J= 8.1 Hz, H-
3 and H-5), 7.42 (2H, d, J = 8.1 Hz, H-2 and H-6) and 7.62 (1H, d, J= 15.9 Hz, H-7) and
Sc at 115.5 (C-8), 115.9 (C-3 and C-5), 127.3 (C-l), 130.0 (C-2 and C-6), 144.6 (C-7),
157.7 (C-4) and 167.4 (C-9).
Table 3: 'H (400 MHz) and 13C NMR (100 MHz) spectroscopic data for
compound 16 in methanol-d4.
Position
1
2,6
3,5
4
7
8
9
r
2', 6'
3', 5'
41
7
8'
ôc (mult.)a
127.3 (s)
130.0 (d)
115.9(0
157.7 (s)
144.6 (d)
115.5 (d)
167.4 (s)
137.9 (s)
128.9 (d)
128.5 (d)
126.6(rf)
35.2 (0
65.0 (t)
SH (mult., J in HZ)
7.42 (d, 8.1)
6.85 (d, 8.1)
7.62 (d, 15.9)
6.29(0 15.9)
7.26 (m)
7.32 (m)
7.25 (m)
3.02 (t, 6.9)
4.42 (t, 6.9)
Multiplicities were deduced from DEPT experiments
31
Table 4: In vitro cytotoxicity results of isolated compounds (l-19)a
Compounds
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Etoposided
A549
> 100
NTC
> 100
NTC
> 100
> 100
>100
81 ±3
9±3
31 ±2
> 100
27 ±3
60 ±10
> 100
19±2
>100
> 100
45.8 ±0.9
> 100
2.8 ±0.5
IC5oOiM±SD)b
DLD-1
>100
NTC
> 100
NTC
> 100
> 100
>100
> 100
9.2 ± 0.9
37 ±3
> 100
23 ±6
>100
>100
19.2 ±0.9
> 100
>100
39 ±3
> 100
2±1
WS1
>100
NTC
> 100
NTC
42 ±4
>100
>100
>100
5.8 ±0.3
87 ±3
>100
20 ±2
42 ±5
> 100
26 ±3
>100
> 100
51±7
>100
>50
a
 Mean values (± standard deviation) for triplicate assays.
b
 Concentration that caused 50% inhibition of cell proliferation.
c
 Not tested.
d
 Positive control.
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Additionally, five overlapped *H NMR signals between SH 7.20-7.30 along with two
méthylène triplets at 3.02 (2H, t, J= 6.9 Hz, H-71) and 4.42 (2H, t, J= 6.9 Hz, H-8') were
attributed to a phenethyl moiety. The HMBC correlation between H-8' and C-9 confirmed
the link between the phenethyl and the/>-coumaroyl groups.
Compounds 10 and 13 were isolated as a mixture. Separation of each constituent was not
performed due to their low amounts. Therefore, careful examination of NMR spectra (!H.
l3C, DEPT and HSQC) and comparison with literature allowed the identification of these
components as rhamnocitrin (10) (29) and kaempferide (13) (26). Moreover, the biological
results were obtained using commercial pure products. Because of low isolated yields of
compounds 3 and 19, those compounds were also tested from commercial materials.
All isolated compounds, except compounds 2 and 4, were evaluated using resazurin
reduction test for their cytotoxicity against human lung cancer (A549), human colorectal
cancer (DLD-1) and normal skin fibroblasts (WS1) (17). Results presented in Table 4 are
expressed as the concentration of product inhibiting cell growth by 50 % (IC50). Etoposide
was used as positive control with IC50 of 2.8 and 2.0 uM against A549 and DLD-1 cell
lines, respectively. The phenolic compounds were regarded as active when the IC50 was
smaller than 100 uM (39). The compound 9 was found the most active with IC50 ranging
from 5.8 to 9.2 uM. Moreover, compounds 10, 12 and 15 were moderately active against
cancer cells with IC50 ranging from 19 to 37 uM. In contrast to compounds 9, 12 and 15,
the compound 10 was significantly selective toward cancer cells with IC50 of 31 uM for
A549 and 37 uM for DLD-1 in comparison to 87 uM for normal cells, WS1. Although the
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cytotoxicity of compounds 9 and 12 were known on A549 cells (40-41), the activity on
human colorectal adenocarcinoma DLD-1 was never reported. Finally, compounds 13 and
18 were found weakly cytotoxic and all the other compounds tested were inactive. As far as
structure-activity relationships are concerned, these in vitro results suggest that the addition
of a double bond in C-2 position in molecule 9, with regard to the compound 11, increases
the cytotoxic activity. Similarly, the presence of a methoxy group in C-7 position and a
hydroxyl in C-4' position in the flavone 9, seem to have a beneficial effect on the cytotoxic
activity in comparison with the acacetin (12), where the inversion of these groups reduces
the activity. On the other hand, the presence of hydroxyl group in R2 of compounds 10 and
13 is detrimental for the activity in comparison with compounds 9 and 12, respectively. In
the case of compounds 15-19, only molecules bearing a benzyl groups exhibited
cytotoxicities (15 and 18). Moreover, hydroxyl group in R1 of compound 18 reduces
significantly the cytotoxicity in comparison to 15. All compounds were also evaluated for
their antibacterial activities against S. aureus and E. coli but no significant activity was
observed.
Concluding remarks
In conclusion, the structure of a new compound 1 was described and 19 compounds were
identified from P. tremuloides. Among them, compounds 2 and 5 were reported for the first
time in Populus genus and compounds 3. 4, 9, 10, 12, 16 and 17 for the first time in
Populus tremuloides. Compound 9 was found the most cytotoxic against lung carcinoma
cell (A549) and colorectal adenocarcinoma (DLD-1) human cell lines. Interestingly, the
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compound 10 was selective toward both cancer cell lines in comparison to normal cells.
Finally, all compounds tested do not possess antibacterial activity.
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Chapter IV
RESULTS AND DISCUSSION:
Other results related to phytochemicai study of
Populus tremuioides
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This chapter is devoted to the detailing of another five purified molecules found in this
species which are not mentioned in chapter III. Thus, other processes of isolation and
characterisation of interesting fractions will be discussed here. In addition, the performed
biologica! assays which were not presented so far will be explained in the next sections.
4.1 Isolation and purification of phenolic compounds
Fraction C2 (12.5 g) was chromatographed on silica gel column chromatography (CC)
using gradient CHCla-MeOH (75:1 —• 15:1, v/v) as eluent to give pure 22 (630 mg).
Subfraction C2.3 was further separated on silica gel CC using CHCb-MeOH gradient (40:1
—> 25:1) as eluent to yield compound 21 (16 mg). Subfraction C2.7 was purified by
preparative HPLC using an isocratic mobile phase of CH3CN-H2O (40:60) to afford pures
20 (11 mg) and 24 (11 mg). Fraction C3 (10.37 g) was separated on silica gel CC using
CHCls-MeOH gradient (15:1 —» 7:1, v/v) as eluent to give 5 fractions. Then, subfraction
C3.2 (1.19 g) was separated into four fractions by passage over silica gel, eluted with
CHCl3-MeOH (20:1) and pure 23 (11 mg) was obtained by preparative HPLC, gradient
MeOH-H2O (50:50-^70:30, v/v).
4.2 Identifiation of purified phenolic compounds
The phenolic compounds presented in figure 5 (20-24) have been identified mainly by
their!H and 13C NMR spectral data and their molecular formula. These compounds are
newly identified products in the P.tremuloides and compounds 20 and 24 were never
reported for family of Salicaceae.
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20 R-,,R3, R5 = OH;R 2 ,R 4 = H
21 R-, = OAC; R2 .R, =H; R3, R5 = OH
22 R1 = OAC; R2 = H; R3,R4, R5 = OH
23 R-, = OAC; R2 , R3, R4,R5 = OH
Figure 5: Five phenolic compounds from buds of P. tremuloides.
4.2.1 Identification of compound 20
The *H and 13C NMR spectra of compound 20 showed the presence of two equivalent p-
coumarate moieties as one doublet at 8H 7.44 (2H, d, J=8.6 Hz) and 6.80 (IE, d, 7=8.6 Hz)
for aromatic rings and 5H 7.66 (1H, d, J= 15.9 Hz) and 6.35 (1H, d, J= 15.9 Hz) for alkene
function (confirmed by 13C NMR spectrum) of trans geometry. Remaining signals 5H 4.28-
4.16 (5H, m) in the *H NMR and 5C 66.2 (t) and 68.4 (d) in the 13C NMR spectra suggested
the presence of a 1,3-0-di-trans-p-coumaroylglycerol. Spectroscopic data of compounds 20
were in agreement with the values reported in the literature [55].
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Table 3: 'H and ' C NMR spectroscopic data for compound 20 in methanol-d4.
Position
1
2
r
2'
3'
4'
7'
8'
9'
5c (mult.)
66.2 (t)
68.4 (d)
126.9 (s)
131.1 (d)
116.7 (d)
161.1 (s)
146.9 (d)
114.7 (d)
168.9 (s)
SH (mult., J in Hz)
4.28 (br d, 5.2)
4.16 (quint, 5.2)
7.44 (d, 8.6)
6.80 (d, 8.6)
7.66 (d, 15.9)
6.35 (d, 15.9}
4.2.2 Identification of compound 21
The *H and !3C NMR spectra of compound 21 indicated the same structure as pure 20
(l,3-O-Di-trans-/?-coumaroylglycerol) excepted for a difference in the triglycerol moiety.
These spectra data (see table 4) confirmed the presence of an acetyl group; 5H 2.08 (3H, s),
§c 20.9 (COCH3), 172 (COCH3), at C-2 of 21 instead of hydroxyl group as in 20. This was
ascertained by *H *H COSY, HMQC and HMBC correlations designed by arrows in figure
6. This molecule is named as 2-acetyl-l,3-dicoumaroylglycerol (Lasiocarpin A) and the
spectroscopic data of compound 21 were in agreement with the values reported in the
literature [56].
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o
Figure 6: 'H 'H COSY, HMQC and HMBC correlations (21).
Table 4: H and C NMR spectroscopic data for compound 21 in methanol-d4.
Position
1
2
r
2'
3'
4'
7'
8'
9'
Ac
CO
Me
Sc (mult.)a
63.5 (t)
71.0 (d)
127.1 (s)
131.4 (d)
116.9 (d)
161.5 (s)
147.3 (d)
114.5 (d)
168.7 (s)
-
172.0 (s)
20.9 (q)
5H (mult., J in Hz) 8H (mult., Jin Hz)
4.47 (dd, 12.1,4.1) 4.35 (dd, 12.1, 5.9)
5.37 (m)
-
7.45 (d, 8.7)
6.79 (d, 8.7)
-
7.63 (d, 15.9)
6.34 (d, 15.9)
-
-
-
2.08 (s)
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4.2.3 Identification of compound 22
The 'H and 13C NMR spectra of compound 22, with [a] D 25 3.16° (c = 0.5, MeOH),
were found to be similar to those of 21, except for a difference in one of the benzene rings
with three protons as one singulet at C-2" SH 7.04 (1H, s), one doublet at C-5" 5H 6.77 (2H,
d, J= 8.4 Hz), and two other as one doublet at C-6" 6H 6.95 (2H, d, J= 8.3 Hz). These
spectral data (see table 5) indicated the presence of a hydroxyl group at C-3" of 22 instead
of two p-coumaroyl groups in 21. Additionally, the presence of two double bound protons
signals at 8H 7.63 (1H, d, J= 15.9 Hz), 5H 6.34 (1H, d, J= 15.9 Hz) and 5H 7.57 (1H, d, J=
15.9 Hz), §H 6.27 (1H, d, /= 15.9 Hz) demonstrated that 2-acetyl-l-caffoyl-3-
coumaroylglycerol (lasiocarpin B) was an asymmetrical triglycéride with acetic, p-
hydroxycinnamic and 3,4-dihydroxy cinnamic acids (figure 6). The spectroscopic data of
compound 22 were in agreement with the values reported in the literature [56].
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Table 5: !H and 13C NMR spectroscopic data for compound 22 in methanol-d4.
Position 5c (mult.)a SH (mult., / i n Hz) ÔH (mult., J in Hz)
1
2
r
2'
3 '
4'
7'
8'
9'
1"
2"
3"
4"
5"
6"
7"
8"
9"
Ac
CO
Me
63.5 CH2
71.1 CH
127.1 (s)
131.4 (d)
116.9 (d)
161.5 (s)
147.3 (d)
114.5 (d)
168.7 (s)
127.6 (s)
115.2 (d)
146.9 (s)
149.8 (s)
116.5 (d)
123.2 (d)
147.7 (d)
114.4 (d)
168.7 (s)
-
172.0 (s)
20.9 (q)
4.47 (ddd, 11.9,4.0,
5.37 (m)
-
7.45 (d, 8.7)
6.79 (d, 8.7)
-
7.63 (d, 15.9)
6.34 (d, 15.9)
-
-
7.04 (d, 2.1)
-
-
6.77 (d, 8.4)
6.95 (dd, 8.3,2.1)
7.57 (d, 15.9)
6.27 (d, 15.9)
-
-
-
2.08 (s)
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4,2.4 Identification of compound 23
The 'H and 13C NMR spectra of compound 23 (see table 6) were similar to those
obtained for 22. However, two olefmic protons at SH 7.57 (1H, d, J= 15.9 Hz) and at 5H
6.27 (1H, d, J- 15.9 Hz) as well as the presence of aromatic rings with three protons as
mentioned above for 22 confirmed a symmetric glycerol ester having an acetyl group at C-2
and two caffeoyl groups at C-l and C-3 as 2-acetyl-l,3-dicaffoylglycerol (Lasiocarpin C)
(see figure 5). The spectroscopic data of compound 23 were in agreement with the values
reported in the literature [56].
Table 6: *H and 13C NMR spectroscopic data for compound 23 in methanol-d4.
Position
1
2
r
2'
3'
4'
5'
6'
T
8'
9'
Ac
CO
Me
5c (mult.)a
63.5 (t)
71.1 (d)
127.6 (s)
115.3 (d)
146.9 (s)
149.8 (s)
116.5 (d)
123.2 (d)
147.7 (d)
114.4 (d)
168.7 (s)
-
172.0 (s)
20.9 (d)
8H (mult., J in Hz)
4.47 (dd, 12.0, 4.0)
5.37 (m)
-
7.04 (d, 1.8)
-
-
6.77 (d, 8.3)
6.95 (dd, 8.3, 1.8)
7.57 (d, 15.9)
6.27 (d, 15.9)
-
-
-
2.08 (s)
§H (mult, / i n Hz)
4.34 (dd, 12.0, 5.8)
-
-
-
-
-
-
-
-
-
-
-
-
-
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4.2.5 Identification of compound 24
The presence of two non-equivalent p-coumarate moieties was detected from the !H
NMR spectrum of compound 24. Additionally, this spectrum showed the presence of a 1,2-
diacylglycerol moiety 5H 5.24 (IH, m), 8H 4.49 (1H, dd, J = 11.8 and 3.8 Hz) and 4.35 (1H,
dd, J = 11.8 and 6.5 Hz) for acylated méthylène protons and §H 3.79 (2H, m) for
hydroxymethyl protons (see table 7). Based on the above spectral data, the structure of 24
was determined as 1,2-dicoumaroylglycerol. This was confirmed by i3C NMR, 'H 'H
COSY, HMQC and HMBC correlations (see figure 7) and the spectroscopic data of
compound 24 were in agreement with the values reported in the literature [56].
Figure 7: 'H H COSY, HMQC and HMBC correlations (24).
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Table 7: 'H and 13C NMR spectroscopic data for compound 24 in methanol-d4.
Position
1
2
3
1'
2'
3'
4'
T
8'
9'
1"
2"
3"
4"
7"
8"
9"
8C (mult.)a
63.8 (t)
73.7 (d)
61.7 (t)
127.2 (s)
131.3 (d)
116.9 (d)
161.4 (s)
147.1 (d)
114.7 (d)
168.9 (s)
127.1 (s)
131.3 (d)
116.9 (d)
161.4 (s)
147.1 (d)
115.0 (d)
168.7 (s)
8H (mult., J in Hz) 8H (mult., J in Hz)
4.49 (dd, 11.8, 3.8) 4.35 (dd, 11.8, 6.5)
5.24 (m)
3.79 (brd, 5.1)
-
7.44 (d, 8.4) 7.04 (d, 1.8)
6.78 (d, 8.4)
-
7.62 (d, 15.9)
6.33 (d, 15.9)
-
-
7.46 (d, 8.4)
6.79 (d, 8.4)
-
7.66 (d, 15.9)
6.37 (d, 15.9)
-
The next section presents the evaluation of anticancer, anti-inflammatory and anti-
bacterial activities of isolated compounds from Populus tremuloides.
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4.3 Evaluation of cytotoxicity against human cell lines
Cytotoxicity of compounds 20-24 have been evaluated against human lung cancer
(A549), human colorectal cancer (DLD-1) and normal skin fibroblasts (WS1) using
resazurin assay as described by O'brien et al. [57]. Resazurin is a non-fluorescent dye
reduced to fluorescent resorufin by living cells. The fluorescent is proportional to the
quantity of cells. Consequently, this assay allows to determine inhibition of cell growth and
cytotoxicity. Resazurin is easy to use as homogeneous assay substrate. It has a fast and
robust read-out potential and usability for a wide range of cell types. On the other hand,
there are possibilities of interaction with test reagents, spontaneous conversion to
fluorescent resafurin and second step conversion of fluorescent resafurin to non-fluorescent
metabolites. These disadvantages may cause conflicts in data interpretation [58]. The
cytotoxicity was also assessed using Hoescht assay as described by Rago et al. [59], which
measure cell DNA quantity, were also carried out to confirm the results of the resazurin
tests. Hoechst stains are part of a family of fluorescent stains for labelling DNA It provides
a linear relationship between fluorescence and DNA content over a broad range of DNA.
This reaction is DNA-specific and does not work with other cellular components such as
RNA, protein, or carbohydrate. This enables the rapid and accurate measurement of cell
number involving minimal processing time, making this assay well suited for cell
proliferation studies [60]. The results presented in table 8 are expressed as the concentration
of compound inhibiting cell growth by 50 % (IC50). The etoposide was used as positive
control, exhibited IC50 of 3.4 ± 0.1, 27 ± 5 and 34 ± 4 uM against A549, DLD-Î and WS1
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respectively for the resazurin test as well as 2.8 ± 0.5, 2 ± 1 and > 50 uM for Hoechst
assay.
Compound 23, never previously reported for anticancer activity, exhibited a significant
cytoxicity against A549 and DLD-1 with IC50 of 9 and 20 uM respectively for the resazurin
tests. Hoechst assays IC50 values were 9 and 12.8 uM. However, compound 23 was not
selective towards cancer cell lines. IC50 values of compound 21 indicated that this molecule
was weakly active on A549 and DLD-1 using both cytotoxic assays, whereas compounds
20, 22 and 24 were found to be inactive (IC5o> 100 uM) against all cell lines tested.
Table 8: In vitro cytotoxicity results of phenolic compounds.
Compounds
20
21
22
23
24
Etopsidee
A-549b
> 100
49 ±6
>100
9±1
>100
3.4 ±0.1
Resazurin
DLD-1C
>100
75 ±5
>100
20 ±1
> 100
27 ±5
IC50(uM)a
WSld
> 100
60 ±3
>100
10 ± 1
>100
34 ±4
A-549
81 ±2
32 ±4
45 ±2
9±1
> 100
2.8 ±0.5
Hoechst
DLD-1
>100
42 ±5
43 ±6
12.8 ± 1
> 100
2 ± 1
WS1
>100
55 ±4
77 ±2
14 ±7
>100
>50
a
 IC50 value of extract which was defined as a concentration that caused 50% inhibition of
cell proliferation.
b
 Human lung carcinoma
c
 Human colorectal adenocarcinoma
d
 Human normal skin fibroblasts
e
 positive control.
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4.4 Evaluation of the anti-inflammatory activity of isolated
compounds on LPS activated RAW264.7 macrophages
Exponentially growing cells were plated in 24-well microplates (BD Falcon) at a
densisty of 2 x 105 cells per well in 400 ul of culure medium and were allowed to adhere
overnight. Cells were then treated or not with positive control N(G)-nitro~L-arginine
methyl ester (L-NAME), or growing concentrations of pure compounds dissolved in the
appropriate solvents, and incubated at 37°C, 5% CO2 for 24h. The final concentration of
solvent in the culture medium was maintained at 0.5% (v/v) to avoid solvent toxicity. Cells
were then stimulated with 10 ug.ml"1 lipopolysaccharide (LPS). After 24h, cell-free
supernatants were collected and stored at -80°C until NO determination using the Greiss
reaction [61] with 1% sulphanilamide and 50 ul of 0.1% N-1-naphtylethylenediamine
dihydrochloride in 2.5% H3PO4 at room temperature for 20 min. Absorbance at 540 nm
was then measured using an automated 96-well Varioskan Ascent plate reader (Thermo
Electron) and the presence of nitrite was quantified by comparison with an NaNO2 standard
curve. All the samples were tested at the highest concentration which presents no
cytotoxicity. Anti-inflammatory activity was expressed as the concentration of drug
inhibiting nitric oxide overproduction by 50% (IC5Q).
The anti-inflammatory activity of phenolic triglycéride component 21 has been reported
to be beneficial in the treatment of chronic inflammatory diseases [62] which prompted us
to examine the activity of similar compounds. In the inflammation process, nitric oxide
(NO) is related to inflammatory reaction and is produced from L-arginine by the inducible
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NO synthase (iNOS) in certain cells activated by various pro-inflammatory agents like
lipopolysaccharide (LPS). Although NO acts as a host defense, it contributes to tissue
injury in inflammatory diseases [63]. Thus, effective inhibition of NO gathering by
inflammatory stimuli represents a beneficial therapeutic strategy.
Anti-inflammatory activity was evaluated using NO inhibition on LPS-activated RAW
264.7 macrophages. NO released from cells is detected and quantified. L-NAME, a NO
synthase inhibitor, prevented the formation of NO in LPS-stimulated RAW 264.7
macrophages [64] and as used as positive control. Resazurin test was also made to ensure
that the reduced production of NO is not related to cytotoxicity. The resazurin assay was
performed with growing concentrations of the extracts ranging from 0 to 40 uM.
The result presented in table 9 show that the compounds 21, 23, and 24 were found
cytotoxic against RAW 264.7 macrophages. Therefore, it is not possible to determine IC50
for these compounds. In contrast the compound 20 and 22 are not cytotoxic for
macrophages. The compound 20 weakly inhibit NO overexpression induced by LPS with
an IC50 of 62 uM. Interestingly, the compound 22 demonstrates a strong inhibition of NO
production with an ICsoof 6.5 uM. In comparison, the IC50 of positive control L-NAME is
about 1 mM.
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Table 9: NO Inhibition induced by phenolic compounds on LPS-activated
RAW 264.7 macrophages.
Compounds
20
21
22
23
24
IC50(fiM)a
62 ± 30b
NDC
6.5 ±0.4
NDC
NDC
a
 IC50 value of extract which was defined as a concentration that caused 50% inhibition of
cell proliferation.
b
 Data represent the mean ± standard deviation of three independent experiments.
c
 ND: not determined due to macrophage cytotoxicity.
4.5 Evaluation of antibacterial activity of compounds isolated
from Populus tremuloides.
The antibacterial activity of compounds 20-23 was tested against two bacteria strains
including gram-positive Staphylococcus aureus (ATCC 25923) and gram-negative
Escherichia coli (ATCC 25922). The S. aureus and E. coli bacteria are implicated in
various pathologies and often responsible for infections contracted in hospitals (nosocomial
infections) [65, 66]. The results are expressed as IC50 (uM) (table 10). Chloramphenicol
was used as positive control in this antibacterial assay with IC50 of >5 uM for S.aureus and
0.37 ± 0.06 uM for E.coli. The results presented in table 10 show that compound 20 and 23
was inactive against S.aureus whereas compound 21 and 22 was found weakly active with
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IC5o of 34 and 59 uM, respectively. Interestingly, the compound 22 and 23 demonstrated
significant antibacterial activity against E.coli with IC50 of 25 and 16 uM, respectively.
Table 10: Antibacterial activity of phenolic compounds against S. aureus and E. coli.
Compounds —
20
21
22
23
Chloramphenicold
S.aureus
Inactivec
34 ±4 b
5 9±5 b
Inactivec
> 5 b
o(pM)a
E.coli
Inactivec
Inactivec
25±2b
16±3b
0.37±0.06b
a
 IC50: concentration of compound inhibiting fifty percent of bacterial proliferation.
b
 Data represent the mean ± standard deviation of three independent experiments.
c
 Pure compound was considered inactive when IC50 >100 uM.
d positive control.
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Chapter VI
CONCLUDING REMARKS AND FUTURE DIRECTIONS
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Very few investigations have been carried out on bioactive constituents of P.
tremuloides which were commonly used by Amerindian traditional medicine to treat
numerous diseases. Some new information about chemical constituent of buds of P.
tremuloides:
• The fraction C from K-BUOH extract showed an important cytotoxic activity against
A549 and DLD-1 cell lines.
• Bioassay-guided fractionation of this fraction with a combination of different
chromatographic techniques led to the isolation of 24 phenolic compounds, namely:
(16',21S)-l-[4-C>-(£)-coumaroyl-^-D-glucopyranosyloxy] cyclohexane-diol (1),
chaenomeloidin (2), prunin (3), echinaticin (4), echinacin (5), tremulacin (6),
salicine (7), tremuloidin (8), genkwanin (9), rhamnocitrin (10), sakuranetin (11),
acacetin (12), kaempferide (13), aromadendrin (14), phenylmethyl coumarate (15),
phenethyl p-coumarate (16), cinnamyl coumarate (17), phenylmethyl caffeate (18),
trans-feruiic acid (19), 1,3-0-di-trans-p-coumaroylglycerol (20), Lasiocarpin A (21),
Lasiocarpin B (22), Lasiocarpin C (23) and 1,2-dicoumaroylglycerol (24).
• Compound 1 is a new molecule and was not reported in literature before.
• Compounds 20 and 24 were not reported before for Salicaceae family.
• Compounds 2 and 5 were not reported before for Populus genus.
• Compounds 3, 4, 9, 10, 12, 16, 17, 21, 22 and 23 were identified for the first time in P.
tremuloides.
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• Compounds 9,12, 15, 18 and 23 exhibited significant inhibitory activities against A549
and DLD-1 cells with IC50 values comprised between 8 and 24 uM.
• It was found, for the first time, that compounds 15 and 23 had anticancer activities.
• Compound 22 exhibited high anti-inflammatory potency towards RAW 264.7 cells.
• Complete 'H, 13C NMR spectroscopic data were performed for compound 15 and 13C
NMR spectroscopic data for compounds 22, 23 and 24. These data were not
reported before.
For future studies, it would be valuable to evaluate the chemical structures and the
corresponding biological activities of molecules in the bark, resin and root of P.
tremuloides or other species of Populus of the boreal forest. Our experiment showed (TLC)
that there were some differences in the materials of bark and resin of P. tremuloides. In
addition, they are suggested to be effective in traditional medicine [9]. It would be
interesting to investigate the synergic effects of isolated molecules for different biological
activities.
It is certainly important to synthetize higher quantities of the bioactive molecules found
in this research to test their other aspects in short and long term. Ultimately, in vivo studies
on most active molecules are essential.
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